Navigation Links
3M Littmann Electronic Stethoscope Model 4100WS with Ambient Noise Reduction

Products3M Littmann Electronic Stethoscope Model 4100WS with Ambient Noise Reduction
Company 3M Worldwide
Item 3M Littmann Electronic Stethoscope Model 4100WS with Ambient Noise Reduction
Features 
  • Amplification is up to 18 times greater than the best non-electronic stethoscopes.
  • Ambient Noise Reduction (ANR) technology.
  • Filter circuitry provides three frequency response modes for listening to heart, lung, and other body sounds: Bell (20-200 Hz), Diaphragm (100-500 Hz), and Extended Range (20-1000 Hz).
  • Digital recording and storage of sounds on six distinct tracks.
  • Infrared transmission of recorded sounds to another Model 4100, Model 4000 or IBM-compatible PC or hand-held device.
  • LCD display in chestpiece, including heart rate readout.
  • Recording and playback capability at normal and half-speed.
  • Sound Analysis Software for PC or Pocket PC allowing a phonocardiogram visual display.
  • 20 hours of continuous use from two AAA alkaline batteries.
  • Excellent acoustic seal and comfortable fit with patented 3M Littmann Snap Tight Soft-Sealing Eartips.
  • Comfortably angled, anatomically correct headset.
  • Patient-friendly, nonchill rim.
  • Chestpiece sized for adult or pediatric patients.
  • Two-year warranty.
Description The Littmann Electronic Stethoscope Model 4100WS features amplification and proprietary Ambient Noise Reduction (ANR) technology allowing you to reduce ambient noise by an average of 75% (-12dB) without eliminating critical body sounds. Three frequency modes are available for listening to heart, lung, and other body sounds: Bell (20-200 Hz), Diaphragm (100-500 Hz), and Extended Range (20-1000 Hz).

In addition, digital signal processing offers recording, storage, and playback capabilities, as well as the ability to transfer recorded sounds via an infrared transmission to another Model 4100 or Model 4000 or IBM-compatible computer or hand-held device.

When combined with the 3M Sound Analysis Software you have an exquisite, state-of-the art auscultation system, which allows you to see what you are hearing via visual display of a phonocardiogram. This "hardware and "software combination will enhance teaching opportunities, serve as a diagnostic aid and help you make more effective use of telemedicine.

Info 3M Worldwide
Customer Service: (888) 364-3577
Web site: http://solutions.3m.com/wps/portal/!ut/p/kcxml/04_Sj9SPykssy0xPLMnMz0vM0Q9KzYsPDdaP0I8yizeIN3b00S_IcFQEAEkU7y4!

Related medicine products :

1. 3M Littmann Sound Analysis Software
2. Littmann Electronic Stethoscope Model 2000
3. Littmann® Electronic Stethoscope Model 3000
4. 3M™ Littmann® Electronic Stethoscope Model 3000
5. MaximEyes Practice Management and Electronic Medical Records Software Solutions
6. PRAXIS® Electronic Medical Records v. 2.19
7. MaximEyes Optometric & Ophthalmology Software for Practice Management and Electronic Medical Records
8. ExamWRITER Electronic Medical Records
9. NextGen Electronic Medical Records module
10. PrimeSuite Integrated Practice Management, Electronic Medical Record (EMR) and Managed Care solutions
11. Cardiology Software for Electronic Medical Records
Precision near-field imaging combined with the best handling IVUS catheter.
Full Digital Ultrasound System
...cho technology constructs images using second harm...and noise than fundamental-frequency components.,...ansmit distortion-free, fundamental-frequency ultr...ltrasound beam is a pure sinusoidal wave, both the...
Aplio was designed for intuitive operation so you can get the results you are looking for quickly and easily. From customizable measurement packages to an ergonomic platform design, Aplio was built m
Medicine Products:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...has not yet prepared dinner for husband Akito, as ...arm laborer, but gambles away whatever he earns. /... often ill, and fearful. Today all three are huddl...s fury. Scenario 2: Madhya Pradesh, India: Rani, ...
...on (CBI) of India on Monday conducted raids in var... the four Indian cities Delhi, Bangalore, Trivandr...e collected important information in connection wi...pments from Pharmaceutical companies. The CBI off...
...taking its toll on Hong Kong teachers, with one in..., a survey has said.// Shouting at students in the... Kong. A survey said dry throats and husky and ha...ymptoms reported by teachers, with female sufferer...
...w study demonstrates that relatives of people with... behaviours linked to the condition, even though t.../ The work, reported in the New Scientist , was ... Society of Neuroscience, in Washington DC by Dr E...
Other Medicine News:Health News:Domestic Violence: The Silent Killer of Women Worldwide 2Health News:Domestic Violence: The Silent Killer of Women Worldwide 3
(Date:9/5/2008).... 5 /PRNewswire-USNewswire/ -- The Florida,Technol...ed Florida,Atlantic University researcher Dr. Herb...r of the Center for Molecular Biology and,Biotechn..., and CHS,Resources LLC (CHS), $184,294 as part of...ssistance Grant program (SURECAG). SURECAG was,est...
(Date:9/5/2008)...t. 5 /PRNewswire-USNewswire/ -- A team of,research.... immigrants from,India and Pakistan take on the h...isks of prostate cancer among male immigrants and ...prostate cancer develop due to many reasons, but,e...le in these cancers,",said Jame Abraham, M.D., med...
(Date:9/4/2008)...t. 4 /- BioForm Medical,In...al clinical study of,Polidocanol, conducted in Ger...k KREUSSLER & Co. GmbH (Kreussler), successfully m...ed to FDA as part of a New Drug Application,(NDA) ...e EASI (Efficacy and safety of,Aethoxysklerol comp...
(Date:9/4/2008).... 4 /- Southern Research Institute,to...th (NIH) has selected,the organization to particip...Production Center Network (MLPCN). The MLPCN -- a ...olecular Libraries Program which is,designed to be...f the human,genome and validate future targets for...
Breaking Medicine Technology:Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Prometic provides information for its Annual and Special Meeting of Shareholders 5041 1Prometic provides information for its Annual and Special Meeting of Shareholders 5041 2Sharing Miracles Television Program to Feature Leave it to Beaver Star Jerry Mathers 18181 1Sharing Miracles Television Program to Feature Leave it to Beaver Star Jerry Mathers 18181 2Sharing Miracles Television Program to Feature Leave it to Beaver Star Jerry Mathers 18181 3Sharing Miracles Television Program to Feature Leave it to Beaver Star Jerry Mathers 18181 4Sharing Miracles Television Program to Feature Leave it to Beaver Star Jerry Mathers 18181 5American Dental Association Stresses Good Oral Health During Pregnancy 18176 1American Dental Association Stresses Good Oral Health During Pregnancy 18176 2Message to Tucson Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 18175 1Message to Tucson Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 18175 2Message to Tucson Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 18175 3Message to Tucson Residents 3A Forgo Fad Dieting and Join the Campaign for Healthy Weight 18175 4
...21, 2007 - Medical,professionals seeking to treat ...ed gram-negative pneumonia may have a new weapon:,...ndidate being,developed by Nektar Therapeutics (Na...evaluating the use of,NKTR-061 (Inhaled Amikacin) ...pital-acquired gram-negative pneumonia were,presen...
...K, Calif.--(BUSINESS WIRE)--May,21, 2007 - ChemGen...the publication of new clinical data relevant to t...ringtonine). The paper "Targeted,therapy and the T...by researchers Simona Soverini and colleagues at t...ume 92, pages 401-404) offers,insight into the gro...
Other Medicine Technology:Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 2Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 3